- Home
- GGR vs CRVO Comparison
GGR vs CRVO Comparison
Compare GGR & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGR
- CRVO
- Stock Information
- Founded
- GGR 2011
- CRVO 2001
- Country
- GGR Taiwan
- CRVO United States
- Employees
- GGR N/A
- CRVO N/A
- Industry
- GGR Auto Manufacturing
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- GGR Consumer Discretionary
- CRVO Health Care
- Exchange
- GGR Nasdaq
- CRVO Nasdaq
- Market Cap
- GGR 114.3M
- CRVO 95.4M
- IPO Year
- GGR N/A
- CRVO N/A
- Fundamental
- Price
- GGR $0.28
- CRVO $8.78
- Analyst Decision
- GGR Hold
- CRVO Strong Buy
- Analyst Count
- GGR 2
- CRVO 8
- Target Price
- GGR $0.50
- CRVO $25.57
- AVG Volume (30 Days)
- GGR 482.8K
- CRVO 345.7K
- Earning Date
- GGR 05-08-2025
- CRVO 05-12-2025
- Dividend Yield
- GGR N/A
- CRVO N/A
- EPS Growth
- GGR N/A
- CRVO N/A
- EPS
- GGR N/A
- CRVO N/A
- Revenue
- GGR $304,551,000.00
- CRVO $9,308,215.00
- Revenue This Year
- GGR N/A
- CRVO N/A
- Revenue Next Year
- GGR $5.00
- CRVO N/A
- P/E Ratio
- GGR N/A
- CRVO N/A
- Revenue Growth
- GGR N/A
- CRVO 15.14
- 52 Week Low
- GGR $0.19
- CRVO $1.80
- 52 Week High
- GGR $1.79
- CRVO $25.69
- Technical
- Relative Strength Index (RSI)
- GGR 50.76
- CRVO 48.86
- Support Level
- GGR $0.27
- CRVO $8.25
- Resistance Level
- GGR $0.31
- CRVO $9.40
- Average True Range (ATR)
- GGR 0.02
- CRVO 0.90
- MACD
- GGR 0.01
- CRVO -0.16
- Stochastic Oscillator
- GGR 52.98
- CRVO 18.43
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.